Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter

Cancer Research

Volumn 63, Issue 17, 2003, Pages 5538-5543

  Volk, Erin L ^a,b   Schneider, Erasmus ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; ELACRIDAR; FOLIC ACID ANTAGONIST; FUMITREMORGIN C; METHOTREXATE; MITOXANTRONE; POLYGLUTAMIC ACID; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RESISTANCE; DRUG TRANSPORT; ENZYME SUBSTRATE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE;

ATP-BINDING CASSETTE TRANSPORTERS; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT, ACTIVE; BREAST NEOPLASMS; CARRIER PROTEINS; CYTOPLASMIC VESICLES; HUMANS; INTRACELLULAR MEMBRANES; METHOTREXATE; MITOXANTRONE; NEOPLASM PROTEINS; OSMOSIS; POLYGLUTAMIC ACID; TUMOR CELLS, CULTURED;

EID: 0141815941     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Alt, F. W., Kellems, R. E., Bertino, J. R., and Schimke, R. T. Selective multiplication of dihydrofolate reductase genes in methotrexate resistant variants of cultured murine cells. J. Biol. Chem., 253: 1357-1370, 1978.
2. Dicker, A. P., Volkenandt, M., Schweitzer, B. I., Banerjee, D., and Bertino, J. R. Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate-resistant Chinese hamster ovary cell line Pro-3 MtxRIII. J. Biol. Chem., 265: 8317-8321, 1990.
3. Yu, M., and Melera, P. Allelic variation in the dihydrofolate reductase gene at amino acid position 95 contributes to antifolate resistance in Chinese hamster cells. Cancer Res., 53: 6031-6035, 1993.
4. Srimatkandada, S., Schweitzer, B. I., Moroson, B. A., Dube, S., and Bertino, J. R. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug. J. Biol. Chem., 264: 3524-3528, 1989.
5. Dixon, K. H., Lanpher, B. C., Chiu, J., Kelley, K., and Cowan, K. H. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J. Biol. Chem., 269: 17-20, 1994.
6. Jansen, G., Mauritz, R., Drori, S., Sprecher, H., Kathmann, I., Bunni, M., Priest, D. G., Noordhuis, P., Schornagel, J. H., Pinedo, H. M., Peters, G. J., and Assaraf, Y. G. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J. Biol. Chem., 273: 30189-30198, 1998.
7. Roy, K., Tolner, B., Chiao, J., and Sirotnak, F. A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. J. Biol. Chem., 273: 2526-2531, 1998.
8. Zhao, R., Sharina, I. G., and Goldman, I. D. Pattern of mutations that results in loss of reduced folate carrier function under antifolate selective pressure augmented by chemical mutagenesis. Mol. Pharmacol., 56: 68-76, 1999.
9. Roy, K., Egan, M., Sirlin, S., and Sirotnak, F. Posttranscriptionally mediated decreases in folylpolyglutamate synthetase gene expression in some folate analogue-resistant variants of the L1210 cell. J. Biol. Chem., 272: 6903-6908, 1997.
10. Rhee, M. S., Wang, Y., Nair, M. G., and Galivan, J. Acquisition of resistance to antifolates caused by enhanced γ-glutamyl hydrolase activity. Cancer Res., 53: 2227-2230, 1993.
11. Hakala, M. T. On the nature of permeability of sarcoma-180 cells to amethopterin in vitro. Biochim. Biophys. Acta, 102: 210-225, 1965.
12. Goldman, I. D. Transport energetics of the folic acid analogue, methotrexate, in L1210 leukemia cells. Enhanced accumulation by metabolic inhibitors. J. Biol. Chem., 244: 3779-3785, 1969.
13. Barakat, R. R., Li, W. W., Lovelace, C., and Bertino, J. R. Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates. Gynecol. Oncol., 51: 54-60, 1993,
14. Dembo, M., Sirotnak, F. M., and Moccio, D. M. Effects of metabolic deprivation on methotrexate transport in L1210 leukemia cells: further evidence for separate influx and efflux systems with different energetic requirements. J. Membr. Biol., 78: 9-17, 1984.
15. Sirotnak, F., and O'Leary, D. The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis- and trans-effects of inhibitors. Cancer Res., 51: 1412-1417, 1991.
16. Schlemmer, S., and Sirotnak, F. Energy-dependent efflux of methotrexate in L1210 leukemia cells. J. Biol. Chem., 267: 14746-14752, 1992.
17. Schlemmer, S., and Sirotnak, F. Retentiveness of methotrexate polyglutamates in cultured L1210 cells. Biochem. Pharmacol., 45: 1261-1266, 1993.
18. Saxena, M., and Henderson, G. B. Identification of efflux systems for large anionic conjugates as the mediators of methotrexate efflux in L1210 cells. Biochem. Pharmacol., 51: 975-982, 1996.
19. Hirohashi, T., Suzuki, H., and Sugiyama, Y. Characterization of the transport properties of cloned rat multidrug Resistance-associated protein 3 (MRP3). J. Biol. Chem., 274: 15181-15185, 1999.
20. Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., and Jansen, G. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res., 59: 2532-2535, 1999.
21. Lee, K., Klein-Szanto, A. J., and Kruh, G. D. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J. Natl. Cancer Inst. (Bethesda), 92: 1934-1940, 2000.
22. Chen, Z. S., Lee, K., Walther, S., Blanchard Raftogianis, R., Kuwano, M., Zeng, H., and Kruh, G. D. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res., 62: 3144-3150, 2002.
23. Zeng, H., Chen, Z-S., Belinsky, M. G., Rea, P. A., and Kruh, G. D. Transport of methotrexate and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res., 61: 7225-7232, 2001.
24. Volk, E. L., Rohde, K., Rhee, M., McGuire, J. J., Doyle, L. A., Ross, D. D., and Schneider, E. Methotrexate cross-resistance in a mitoxantrone-selected multidrug resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. Cancer Res., 60: 3514-3521, 2000.
25. Miyake, K., Mickley, L., Litman, T., Zhan, Z., Robey, R., Cristensen, B., Brangi, M., Greenberger, L., Dean, M., Fojo, T., and Bates, S. E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res., 59: 8-13, 1999.
26. Allikmets, R., Schriml, L., Hutchinson, A., Romano-Spica, V., and Dean, M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res., 58: 5337-5339, 1998.
27. Klein, I., Sarkadi, B., and Varadi, A. An inventory of the human ABC proteins. Biochim. Biophys. Acta, 1461: 237-262, 1999.
28. Volk, E. L., Farley, K. M., Wu, Y., Li, F., Robey, R. W., and Schneider, E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res., 62: 5035-5040, 2002.
29. Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma J. Natl. Cancer Inst. (Bethesda), 51: 1409-1413, 1973.
30. Nakagawa, M., Schneider, E., Dixon, K. H., Horton, J., Kelley, K., Morrow, C., and Cowan, K. H. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant MCF-7 breast cancer cells. Cancer Res., 52: 6175-6181, 1992.
31. r 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res., 58: 5130-5136, 1998.
32. Steck, T. L., and Kant, J. A. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol., 31: 172-180, 1974.
33. Saxena, M., and Henderson, G. B. MOAT4, a novel multispecific organic-anion transporter for glucuronides and mercapturates in mouse L1210 cells and human erythrocytes. Biochem. J., 320: 273-281, 1996.
34. Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Perez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M., and Bates, S. E. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res., 61: 6635-6639, 2001.
35. Allen, J. D., Jackson, S. C., and Schinkel, A. H. A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for doxorubicin resistance. Cancer Res., 62: 2294-2299, 2002.
36. Rabindran, S. K., He, H., Singh, M., Brown, E., Collins, K. I., Annable, T., and Greenberger, L. M. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res., 58: 5850-5858, 1998.
37. Rabindran, S. K., Ross, D. D., Doyle, L. A., Yang, W., and Greenberger, L. M. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res., 60: 47-50, 2000.
38. Robey, R. W., Medina-Perez, W. Y., Nishiyama, K., Lahusen, T., Miyake, K., Litman, T., Senderowicz, A. M., Ross, D. D., and Bates, S. E. Overexpression of the ATP-binding cassette half-transporter. ABCG2 (MXR/BCRP/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin. Cancer Res., 7: 145-152, 2001.
39. Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P. C., and Doyle, L. A. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J. Natl. Cancer Inst (Bethesda)., 91: 429-433, 1999.
40. Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., and Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 95: 15665-15670, 1998.
41. Bakos, E., Evers, R., Sinko, E., Varadi, A., Borst, P., and Sarkadi, B. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol., 57: 760-768, 2000.
42. Heijn, M., Hooijberg, J. H., Scheffer, G. L., Szabo, G., Westerhoff, H. V., and Lankelma, J. Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim. Biophys. Acta, 1326: 12-22, 1997.
43. Masuda, M., I'izuka, Y. Yamazake, M., Nishigaki, R., Kato, Y., Ni'inuma, K., Suzuki, H., and Sugiyama, Y. Methotrexate is excreted into the bile by canicular multispecific organic anion transporter in rats. Cancer Res., 57: 3506-3510, 1997.
44. Masson, E., Relling, M. V., Synold, T. W., Liu, Q., Schuetz, J. D., Sandlund, J. T., Pui, C-H., and Evans, W. E. Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. J. Clin. Investig., 97: 73-80, 1996.
45. Whitehead, V., Payment, C., Cooley, L., Lauer, S., Mahoney, D., Shuster, J., Vuchich, M-J., Bernstein, M., Look, A., Pullen, D., and Camitta, B. The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Leukemia (Baltimore). 15: 1081-1088, 2001.
46. Panetta, J., Yanishevski, Y., Pui, C., Sandlund, J., Rubnitz, J., Rivera, G., Ribiero, R., Evans, W., and Relling, M. A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia. Cancer Chemother. Pharm. 50: 419-428, 2002.